Results 311 to 320 of about 495,708 (385)

Placebo misery. Escaping from placebo prison.

BMJ (Clinical research ed.), 2009
openaire   +3 more sources

The Impact of Self‐Checkout Technology on Shopping Behavior in B2B Retail: Evidence From Point‐Of‐Sale Transaction Data

Journal of Consumer Behaviour, EarlyView.
ABSTRACT This study examines the impact of self‐checkout technology implementation on B2B customer shopping behavior using a novel methodological approach that combines propensity score matching with difference‐in‐differences analysis on actual point‐of‐sale transaction data.
Jindřich Špička, Michaela Dvořáková   +1 more
wiley   +1 more source

Efficacy of open-label placebos for premenstrual syndrome: a randomised controlled trial. [PDF]

BMJ Evid Based Med
Frey Nascimento A, Gaab J, Degen B, Rytz M, Holder A, Sezer D, Buergler S, Meyer AH, Kirsch I, Kossowsky J, Locher C.   +10 more
europepmc   +1 more source

Dekonstruktion af Placebo Effekten og fundet af Betydningsrespons: (oversættelse af originalartikel af Daniel Moerman & Wayne Jonas: Deconstructing the Placebo Effect and Finding the Meaning Response)

, 2015
Ann Ostenfeld-Rosenthal, Helle Johannessen   +1 more
openalex   +1 more source

Skin evaluation of turmeric/epigallocatechin-3-gallate emulgel for skin irritation and sensitisation effects in healthy Thai participants (TULIP): a protocol for a randomised, double-blind, placebo-controlled trial

Kankanit Yeerong, Chadarat Ampasavate, Ajaree Rayanakorn, Mati Chuamanochan, Napatra Tovanabutra, Mingkwan Na Takuathung, Nut Koonrungsesomboon   +6 more
openalex   +1 more source

Contemporary and Emerging Therapies in the Management of Refractory Angina: A Clinical Review

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Refractory angina (RA) represents a growing challenge in clinical cardiology, particularly in patients with obstructive coronary artery disease (CAD) who remain symptomatic despite optimal medical therapy and who are not candidates for revascularization.
Alex Angers‐Goulet, Siddhartha Mengi, David Garcia Labbé, Can Manh Nguyen, Jean‐Michel Paradis   +4 more
wiley   +1 more source

Random-effects meta-analysis models for pooling rare events data: a comparison between frequentist and bayesian methods. [PDF]

BMC Med Res Methodol
Yao M, Deng K, Wang Y, Mei F, Zou K, Li L, Sun X.   +6 more
europepmc   +1 more source

The placebo and design research [PDF]

, 2012
Cash, Philip
core  

A double-blinded placebo-controlled parallel design trial to determine whether inhibiting intestinal sweet taste sensing improves glycaemic responses in patients with type 2 diabetes

Young, Dr Richard
openalex   +1 more source

Effects of High‐ and Low‐Fat Meals on the Bioavailability and Pharmacokinetics of Votoplam, a HTT Gene Splicing Modifier

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Votoplam is a novel, orally bioavailable, small molecule HTT gene splicing modifier that is being developed for the treatment of Huntington's disease. This was a single dose, open‐label, two‐period, crossover food effect study that evaluated the effect of high‐ and low‐fat meals on 20 mg votoplam in healthy participants. There was a washout of
Lucy Lee, Amy‐Lee Richards, Nageswara Reddy, Brian Beers, Lee Golden, Ronald Kong   +5 more
wiley   +1 more source